Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

Peter Voorhees, MD
Videos
Choosing the Optimal Treatment for Patients With Newly Diagnosed Multiple Myeloma
05/03/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting, Peter M. Voorhees, MD, shared strategies for selecting a frontline therapy for patients with multiple myeloma.
At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting, Peter M. Voorhees, MD, shared strategies for selecting a frontline therapy for patients with multiple myeloma.
At the 2023 Great Debates &...
05/03/2023
Oncology
Joseph Mikhael, MD
Videos
Strategies for Treating Patients With Multiple Myeloma in Early Relapse
05/02/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting in New York, New York, Joseph Mikhael, MD, shared strategies for treating patients with multiple myeloma in early relapse.
At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting in New York, New York, Joseph Mikhael, MD, shared strategies for treating patients with multiple myeloma in early relapse.
At the 2023 Great Debates &...
05/02/2023
Oncology
Melissa Alsina, MD, Moffitt Cancer Center
Videos
Looking to the Future of Treatment Options for Patients With Multiple Myeloma
05/02/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Melissa Alsina, MD, discussed possible future treatment options for patients with myeloma.
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Melissa Alsina, MD, discussed possible future treatment options for patients with myeloma.
At the 2023 Great Debates &...
05/02/2023
Oncology
Saad Usmani Memorial Sloan Kettering Cancer Center
Videos
Novel and Cellular Therapies to Treat Patients With R/R Multiple Myeloma
05/02/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Saad Z. Usmani, MD, MBA, FACP, discussed novel and cellular therapies used to treat relapsed/refractory multiple myeloma, including but not...
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Saad Z. Usmani, MD, MBA, FACP, discussed novel and cellular therapies used to treat relapsed/refractory multiple myeloma, including but not...
At the 2023 Great Debates &...
05/02/2023
Oncology
Andrew Artz MD City of Hope
Videos
Benefits of HSCT for Patients With AML With MRD After Initial Therapy
04/27/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies meeting in New York, New York, Andrew Artz, MD, participated in a debate about the benefits of hematopoietic stem cell transplantation among patients with AML with MRD after...
At the 2023 Great Debates & Updates in Hematologic Malignancies meeting in New York, New York, Andrew Artz, MD, participated in a debate about the benefits of hematopoietic stem cell transplantation among patients with AML with MRD after...
At the 2023 Great Debates &...
04/27/2023
Oncology
Amer Zeidan Yale Cancer Center
Videos
Effective Risk Stratification for Patients With Myelodysplastic Syndromes
04/26/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Amer Zeidan, MBBS, MHS, discussed effective risk stratification among patients with myelodysplastic syndromes.
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Amer Zeidan, MBBS, MHS, discussed effective risk stratification among patients with myelodysplastic syndromes.
At the 2023 Great Debates &...
04/26/2023
Oncology
Richard Stone, MD
Videos
Considering MRD Before HSCT for Patients With Acute Myeloid Leukemia
04/25/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, Richard Stone, MD, debated the role of measurable residual disease when considering hematopoietic stem cell transplantation for patients with acute...
At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, Richard Stone, MD, debated the role of measurable residual disease when considering hematopoietic stem cell transplantation for patients with acute...
At the 2023 Great Debates &...
04/25/2023
Oncology
Elizabeth Brem University of California Irvine
Videos
Analyzing Patient Selection and the Utility of CNS Prophylaxis for Patients With DLBCL
04/20/2023
In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Elizabeth A. Brem, MD, analyzed the role of central nervous system prophylaxis for patients with DLBCL.
In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Elizabeth A. Brem, MD, analyzed the role of central nervous system prophylaxis for patients with DLBCL.
In a debate at the 2023 Great...
04/20/2023
Oncology
Elizabeth Brem University of California Irvine
Videos
Analyzing Patient Selection and the Utility of CNS Prophylaxis for Patients With DLBCL
04/20/2023
In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Elizabeth A. Brem, MD, analyzed the role of central nervous system prophylaxis for patients with DLBCL.
In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Elizabeth A. Brem, MD, analyzed the role of central nervous system prophylaxis for patients with DLBCL.
In a debate at the 2023 Great...
04/20/2023
Oncology
Jennifer Amengual, MD, Columbia University
Videos
Choosing Treatment Options for Patients With R/R DLBCL Ineligible for CAR T-Cell Therapy
04/18/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies in New York, New York, Jennifer Amengual, MD, discussed the process of choosing among non-CAR-T options for patients with recurrent aggressive lymphoma, particularly DLBCL.
At the 2023 Great Debates & Updates in Hematologic Malignancies in New York, New York, Jennifer Amengual, MD, discussed the process of choosing among non-CAR-T options for patients with recurrent aggressive lymphoma, particularly DLBCL.
At the 2023 Great Debates &...
04/18/2023
Oncology

Advertisement

About

At Great Debates and Updates in Hematologic Malignancies, nationally recognized thought leaders take opposing sides on clinical—and sometimes controversial—topics currently disrupting the practice of hematology and oncology.

Through comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.

Platinum Sponsors

johnson & johnson

 

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use